Continue with FacebookLooking to list your PhD opportunities? Log in here.
patient safety PhD Projects, Programmes & Scholarships
We have 15 patient safety PhD Projects, Programmes & Scholarships
PhD saved successfully
Last chance to apply
National Institute for Health and Care Research (NIHR) Patient Safety Research Collaborative (PSRC) PhD studentship
Award summary. To deliver real and meaningful changes in patient safety for those with Multiple Long-Term Conditions (MLTCs). https://www.newcastle-hospitals.nhs.uk/news/5-3million-investment-for-patient-safety-research/. Read more
Exploring the safety risks and benefits of virtual wards
Research Group:
Medicines Optimisation
Do you want to address an important research question to inform healthcare policy practice?. Do you want to do cutting-edge research and develop a career in health services or patient safety research? . Read more
Innovative Biological Scaffolds for Regenerative Replacement of Dysfunctional Heart Valves
The School of Biomedical Sciences invites applications from prospective postgraduate researchers who wish to commence study for a PhD in the academic year 2023/24. Read more
Applied Dementia Studies (PhD, Faculty of Health Studies)
Study a PhD at the University of Bradford and contribute new and significant knowledge to the field of Applied Dementia Studies. Doctoral studies at Bradford focus on improving care, health and wellbeing of people with, or affected by, dementia. Read more
Tackling antibiotic seeking in behaviour in veterinary and dental practices
Antimicrobial resistance is a global health and patient safety emergency driven by the unnecessary use of antimicrobial drugs. Dentistry is responsible for around 10% of antibiotics globally, with up to 80% unnecessary of inappropriate use. Read more
Sheffield Hallam University PhD Scholarship: Co-design of a Patient-Centric Cancer Prehabilitation Chatbot
Applications are invited for a Co-design of a Patient-Centric Cancer Prehabilitation Chatbot PhD Scholarship, at the Academy of Sport and Physical Activity, commencing February 2024. Read more
Unlocking Insights from Real-World Evidence: Exploring the Safety of Drug Combinations (NDORMS 2024/2)
Adverse drug reactions (ADRs) are unintended, harmful events attributed to the use of medicines. In modern healthcare, ADRs pose a significant challenge due to the complexity of therapeutics, an aging population, and rising multimorbidity. Read more
MRI-guided Robotic-assisted Neurosurgery at 0.55T
Applications are invited for a fully funded 3,5 year full-time PhD studentship (including home tuition fees, annual stipend and consumables) starting on 1st February 2024. Read more
Subgroup effects in antihypertensive and type 2 diabetes drug classes: a comparative effectiveness and safety study integrating real-world and genetic data
Commercial partner: Janssen. Pharmaceutical Companies of Johnson & Johnson. Estimating subgroup treatment effects from clinical trials is notably difficult due to the limited sample size and under-representation of patients with multimorbidity. Read more
Clinical-Engineering Post-Market Surveillance of Growing Spine Rods
Project Title: Clinical-Engineering Post-Market Surveillance of Growing Spine Rods. Degree Level: PhD (note all UCL students first register as MPhil students). Read more
NIHR Biomedical Research Centre Digital Health PhD: Decentralised Clinical Trials in practice: Optimising trial design and delivery for real-time monitoring
NIHR Biomedical Research Centre Digital Health PhD. Decentralised Clinical Trials in practice. Optimising trial design and delivery for real-time monitoring. Read more
Molecular characterisation of a novel transporter for the atypical antipsychotic clozapine
Schizophrenia is a severe psychiatric illness affecting about 24 million people worldwide. Schizophrenia can have a devastating effect on a patient’s life and is associated with increased mortality, with life expectancy reduced on average by 15 years compared to that of the general population. Read more
Real world evidence in the study of different subtypes of breast, lung, and prostate cancers: phenotyping, synthetic arm trials, and target trial emulation (NDORMS 2024/9)
Precision medicine in oncology is changing the prognosis of numerous cancers. However, the identification of very specific and rare cancer subtypes is leading to challenges in the recruitment of enough subjects for randomised controlled trials. Read more
Translational Medicine: Understanding the mechanism(s) of resistance to EPA to personalise therapy and improve outcome
Advanced colorectal cancer (CRC) is the UK’s second most lethal cancer, with limited treatment options for unresectable metastatic tumours. Read more
Investigating the experience of infection control education of student nurses in the UK
The two greatest challenges facing global healthcare are the ongoing Covid-19 pandemic and the insidious rise of anti-microbial resistant infections (AMR). Read more
- 1
